Integrative Multi-Omics Analysis Reveals the Characteristic Metabolic…
A simple blood test showing seven metabolites can now detect gliomas with over 96% accuracy, potentially offering families faster, noninvasive diagnosis.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Phase II study of olaparib and durvalumab in patients with metastatic…
Combining two cancer drugs works much better for prostate cancer patients carrying BRCA2 mutations, pointing toward personalized treatment strategies.
Near-term implementable findingModel-based evaluation of colorectal cancer screening effectiveness
Home stool DNA tests done every three years catch more precancerous growths and prevent more colorectal cancers than colonoscopy alone, helping more people get screened.
Near-term implementable findingDiagnostic performance and clinical implications of the World Health…
A new standardized system for reading lymph node biopsies achieves 96% accuracy with flow cytometry, improving confidence in cancer diagnosis.
Near-term implementable findingC-reactive protein-triglyceride-glucose index is an independent…
A new blood marker combining inflammation and insulin resistance better predicts heart disease deaths in people with metabolic syndrome, sharpening risk assessment.